Research Program

George R ThompsonThe UC Davis Center for Valley Fever Core Faculty have a decades long history of work in clinical care, the development of diagnostic testing, and basic research in coccidioidomycosis. Our work spans the full spectrum from clinical trials to basic science and includes both human and veterinary science.

(Click one of the below Research areas for more information)

Clinical Care and Translational Work

  1. Hoffmann WJ, McHardy I, Thompson GR III. Itraconazole Induced Hypertension and Hypokalemia: mechanistic evaluation. Manuscript accepted for publication. Mycoses.
  2. Thompson GR III, Lewis JS, Nix DE, Patterson TF. Current Concepts and Future Directions in the Pharmacology and Treatment of Coccidioidomycosis. Manuscript under review. Medical Mycology invited paper. 2017
  3. Stewart ER, Eldridge ML, McHardy I, Cohen SH, Thompson GR III. Liposomal Amphotericin B as Monotherapy in Relapsed Coccidioidal Meningitis. Manuscript accepted for publication. Mycopathologia.
  4. Ling JL, Bays DJ, Thompson GR III, Moshiri A, Mannis MJ. Favorable Outcome in Coccidioides endophthalmitis – a Combined Medical and Surgical Treatment Approach. Cornea. 2017 Nov;36(11):1423-1425. PMID: 28872517
  5. Thompson GR III, Chang D, Wittenberg RR, McHardy I, Semrad A. Posaconazole Induced Hypertension and Hypokalemia:In vivo 11β-hydroxysteroid dehydrogenase Inhibition. Antimicrobial Agents and Chemotherapy. 2017 August 61(8):e00760-17; 1-4. PMID: 28533238
  6. Thompson GR III, Blair J, Wang S, Bercovitch R, Bolaris M, Van Den Akker D, Lopez R, Heidari A, Catanzaro A, Cadena J, Chin-Hong P, Spellberg B, Johnson R. Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis. Clinical Infectious Diseases. 15 July 2017;65(2):338–41. PMID: 28419259
  7. Thompson GR III, Barker B, Wiederhold NP. Large Scale Evaluation of in vitro Amphotericin B, Triazole, and Echinocandin activity against Coccidioides species from United States Institutions. Antimicrobial Agents and Chemotherapy. 2017 April 61(4):e02634-16; 1-4. PMID: 28096163
  8. Thompson GR III, Rendon A, Santos R, Queiroz-Telles F, Ostrosky-Zeichner L, Zeiher B, Maher R, Lee M, Kovanda L, Vazquez J, Cornely OA, Perfect JR. Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses. Clinical Infectious Diseases. 2016 Aug 1;63(3):356-62. PMID: 27169478
    *Featured in New England Journal of Medicine Journal Watch
    *Featured in Faculty of 1000
  9. Schwartz IS, Kenyon C, Thompson GR III. Endemic Mycoses: What’s new about old diseases? Current Clinical Microbiology Reports. 2016 3:71–80
  10. Stockamp N, Thompson GR III. Coccidioidomycosis. Infectious Disease Clinics of North America. 2016 Mar;30(1):229-46. PMID: 26739609
  11. Twarog M, Thompson GR III. Coccidioidomycosis: Recent Updates. Seminars in Respiratory and Critical Care Medicine. 2015 Oct;36(5):746-55. PMID: 26398540
  12. Hodge G, Cohen SH, Thompson GR III. Intrathecal Therapy with Amphotericin B – potential pharmacodynamics interactions with concurrently administered hydrocortisone. Medical Mycology. 2015 Sep 1;53(7):749-53. PMID: 26162473
  13. Thompson GR III, Stevens DA, Clemons KV, Fierer J, Johnson RH, Sykes J, Rutherford G, Peterson M, Taylor JW, Chaturvedi V. Call for a California Coccidioidomycosis Consortium to Face the Top Ten Challenges Posed by a Recalcitrant Regional Disease. Mycopathologia. 2015 Feb;179(1-2):1-9. PMID: 25318989
  14. Zhu ES, Thompson GR III, Kreulen C, Giza E. Amphotericin B-impregnated Bone Cement to Treat Refractory Coccidioidal Osteomyelitis. Antimicrobial Agents and Chemotherapy. 2013. 2013 Dec;57(12):6341-3. PMID: 24002101
  15. Thompson GR III, Wang S, Bercovitch R, Bolaris M, Akker DVD, Taylor S, Lopez R, Catanzaro A, Cadena J, Chin-Hong P, Spellberg B. Routine CSF Analysis in Coccidioidomycosis is Not Required. PLOS One. 2013; May 21;8(5):e64249; 1-5. PMID: 23717579
  16. Thompson GR III, Bays DJ, Taylor SL, Cohen SH, Pappagianis D. Association Between Serum 25-Hydroxyvitamin D Level and Type of Coccidioidal Infection. Medical Mycology. 2013 Apr;51(3):319-23. PMID: 22680977
  17. Sharma S, Thompson GR III. How I Treat Coccidioidomycosis. Current Fungal Infection Reports. 2013; 7(1):29-35.
  18. Marsden-Haug N, Goldoft M, Ralston C, Limaye AP, Chua J, Hill H, Jecha L, Thompson GR III, Chiller T. Coccidioidomycosis Acquired in Washington State. Clinical Infectious Diseases. 2013 Mar;56(6):847-50. PMID: 23223598
  19. Pappagianis D, Johnson SM. Revision and return of a coccidioidal skin test reagent. Mycopathologia, 2012 174(5-6):351-2.
  20. Thompson GR III. Strategies to Combat Coccidioidomycosis: Are We Making Any Progress? Current Fungal Infection Reports. 2011; 5:215–223
  21. Nelson EC, Thompson GR III, Vidovszky TJ. Coccidioidomycosis Mimicking Peritoneal Carcinomatosis. Archives of Surgery. 2012; Jan;147(1):95. PMID: 22250124
  22. Thompson GR III. Pulmonary Coccidioidomycosis. Respiratory and Critical Care Medicine. 2011; Dec;32(6):754-63. PMID: 22167403
  23. Thompson GR III, Bays D, Cohen SH, Pappagianis D. Fluoride Excess in Coccidioidomycosis Patients Receiving Long-Term Antifungal Therapy: An assessment of currently available triazoles. Antimicrobial Agents and Chemotherapy. 2012 Jan;56(1):563-4. PMID: 22005993
    *Featured in Faculty of 1000
  24. Thompson GR III, Lunetta JM, Johnson SM, Taylor S, Bays D, Cohen SH, Pappagianis D. Early Treatment with Fluconazole may Abrogate the Development of IgG Antibodies in Coccidioidomycosis. Clinical Infectious Diseases. 2011; Sep;53(6):e20-4. PMID: 21865185 *Featured as one of top 10 papers of the year in clinical mycology; 51st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Chicago, Il: 2011.
  25. Bercovitch RS, Catanzaro A, Schwartz BS, Pappagianis D, Watts DH, Ampel NM. Coccidoidomycosis during pregnancy: a review and recommendation for management. Clin Infec Dis, 2011 53(4):363-8.
  26. Thompson GR III, Lewis JS II. Pharmacology and clinical use of voriconazole. Expert Opinion on Drug Metabolism and Toxicology. 2009;6(1):83-94. PMID: 19947892
  27. Lat A, Thompson GR III. Update on the Optimal Use of Voriconazole for Invasive Fungal Infections. Infection and Drug Resistance. 2011;4:43-53. PMID: 21694908
  28. Thompson GR III, Wiederhold NP. Isavuconazole: A Comprehensive Review of Existing Data. Mycopathologia. 2010 Nov;170(5):291-313. PMID: 20524153
  29. Stevens DA, Clemons KV, Levine Hb, Pappagianis D, Baron EJ, Hamilton JR, Deresinski SC, Johnson N. Expert opinion: what to do when there is Coccidioides exposure in a laboratory. Clinical Infectious Diseases. 2009 49(6):919-23.
  30. Berry CD, Stevens DA, Hassid EL, Pappagianis D, Happs EL, Sahrakar K. A new method for the treatment of chronic fungal meningitis: continuous infusion into the cerebrospinal fluid for coccidioidal meningitis. American Journal of the Medical Sciences. 2009 338(1):79-82.
  31. Pappagianis, D. Coccidioidomycosis in California State Correctional Institutions. Annals of the New York Academy of Science. 2006 Sep, 1111:103-11.
  32. Crum, N.F., Potter, M., Pappagianis, D. Seroincidence of Coccidioidomycosis during military desert training exercises. J. Clin Microbiol. 2004. Oct: 42(10): pp. 4552-5.
  33. Wright, P.W., Pappagianis D, M. Wilson, A. Louso, S.A. Moser, K. Komatsu, and P.G. Pappas. Donor-related Coccidioidomycosis in organ transplant recipients. Clinical Infectious Diseases. 2003 37:1265-1269.
  34. Clemons KV, Sobel RA, Williams PL, Pappagianis D, Stevens DA. Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidiodal meningitis in rabbits. Antimicrobial Agents and Chemotherapy. 2002 46:2420-2426.
  35. Sorensen KN, Sobel RA, Clemons KV, Calderon L, Howell KJ, Irani PR, Pappagianis D, Williams PL, Stevens DA. Comparative efficacies of terbinafine and fluconazole in treatment of experimental coccidioidal meningitis in a rabbit model. Antimicrobial Agents and Chemotherapy. 2000 44:3087-3091.
  36. Mendes RP, Negroni r, Bonifaz A, Pappagianis D. New aspects of some endemic mycoses. Medical Mycology. 2000 38(Suppl. 1): 237-241.
  37. Sorensen KN, Sobel RA, Clemons KV, Pappagianis D, Stevens DA, Williams PL. Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis. Antimicrobial Agents and Chemotherapy. 2000 44:1512-1517.
  38. Cairns LD, Blythe D, Kao A, Pappagianis D, Kaufman L, Kobayashi J, Hajjeh R. Outbreak of coccidioidomycosis in Washington State residents returning from Mexico. Clinical Infectious Diseases. 2000 30:61-64.
  39. Johnson SM, Zimmermann CR, Kerekes KM, Davidson A, Pappagianis D. Evaluation of the susceptibility of Coccidioides immitis to lufenuron, a chitin synthase inhibitor. Medical Mycology. 1999 37:441-444.
  40. Dosanjh A, Theodore J, Pappagianis D. Probable false positive coccidioidal serologic results in patients with cystic fibrosis. Pediatric Transplantation. 1999 2:313-317.
  41. Williams PL, Sobel RA, Sorensen KN, Clemons KV, Shuer LM, Royaltey SS, Yao Y, Pappagianis D, Lutz JE, Reed C, River ME, Lee BC, Bhatti SU, Stevens DA A model of coccidioidal meningoencephalitis and cerebrospinal vasculitis in the rabbit. Journal of Infectious Diseases. 1998 178:1217-1221.
  42. Schneider E, Hajjeh RA, Spiegel RA, Jibson RW, Harp EL, Marshall GA, Gunn RA, McNeil MM, Pinner RW, Baron RC, Burger RC, Hutwagner LC, Crump C, Kaufman L, Reef SE, Feldman GM, Pappagianis D, Werner SB., et al. A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. Journal of the American Medical Association. 1997 277:904-908.
  43. Pappagianis D. Current and future approaches to the diagnosis of Coccidioidomycosis, p. 116-128, In H. Einstein and A Cantanzaro (eds), Proceedings of the 5th Centennial Conference on Coccidioidomycosis. National Foundation for Infectious Diseases, Bethesda, MD. 1996
  44. Peterson CM, Schuppert K, Kelly PC, Pappagianis D. Coccidioidomycosis and pregnancy. Obstetrical and Gynecological Survey. 1993, 48:149-156.
  45. Williams PL, Johnson R, Pappagianis D, Einstein H, Slager U, Koster FT, Eron JJ, Morrison J, Aguet J, River ME. Vasculitic and encephalitic complications associated with Coccidioides immitis infection of the central nervous system in humans: report of 10 cases and review. Clinical Infectious Diseases. 1992, 14:673-682.
  46. Fish DG, Ampel NM, Galgiani JN, Dols CL, Kelly PC, Johnson CH, Pappagianis D, Edwards JE, Wasserman RB, Clark RJ et al. Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine. 1990; 69:384-391.
  47. Pappagianis D, Zimmer BL, Theodoropoulos G, Plempel M, Hector RF. Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis. Antimicrobial Agents and Chemotherapy. 1990; 34:1132-1138.
  48. Hector RF, Zimmer BL, Pappagianis D. Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis and blastomycosis. Antimicrobial Agents and Chemotherapy. 1990; 34:587-593.
  49. Hector RF, Zimmer BL, Pappagianis D. Microtiter method for MIC testing with spherule-endospore-phase Coccidioides immitis. Journal of Clinical Microbiology. 1988; 26:2667-2668.
  50. Castaneda E, Brummer E, Pappagianis D, Stevens DA. Chronic pulmonary and disseminated paracoccidioidomycosis in mice: quantitation of progression and chronicity. Journal of Medical and Veterinary Mycology. 1987; 25:377-387.
  51. Wolf JE, Little JR, Pappagianis D, Kobayashi GS. Disseminated coccidioidomycosis in a patient with the acquired immune deficiency syndrome. Diagnostic Microbiology of Infectious Disease. 1986; 5:331- 336.
  52. Galgiani J. and the Valley Fever Vaccine Study Group [Pappagianis D]. Development of dermal hypersensitivity to coccidioidal antigens associated with repeated skin testing. American Review of Respiratory Disease. 1986; 134:1045-1047.
  53. Deresinski SC, Pappagianis D, Stevens DA. Association of ABO blood group and outcome of coccidioidal infection. Sabouraudia. 1979; 17:261-264.
  54. Pappagianis D, Lindsay S, Beall S, Williams P. Ethnic background and the clinical course of coccidioidomycosis. American Review of Respiratory Disease. 1979; 120:959-961.
  55. Harvey RP, Pappagianis D, Cochran J, Stevens DA. Otomycosis due to coccidioidomycosis. Archives of Internal Medicine. 1978; 138:1434-1435.
  56. Collins MS, Pappagianis D. Uniform susceptibility of various strains of Coccidioides immitis to amphotericin B. Antimicrobial Agents and Chemotherapy. 1977; 11:1049-1055.
  57. Collins MS, Pappagianis D. Treatment of murine coccidioidomycosis with polymyxin B. Antimicrobial Agents and Chemotherapy. 1976; 10:318-321.
  58. Huppert M, Pappagianis D, Sun SH, Gleason-Jordan I, Collins MS, Vukovich KR. Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo. Antimicrobial Agents and Chemotherapy. 1976; 9:406-413.
  59. Winter WG, Larson RK, Honeggar MM, Jacobsen DT, Pappagianis D, Huntington RW. Coccidioidal arthritis and its treatment--1975. Journal of Bone and Joint Surgery. 1975; 57-A:1152-1157.
  60. Collins MS, Pappagianis D. Inhibition of Coccidioides immitis in vitro and enhancement of anticoccidioidal effects of amphotericin B by polymyxin B. Antimicrobial Agents and Chemotherapy. 1975; 7:781-787.
  61. Pappagianis D, Levine HB. The present status of vaccination against coccidioidomycosis in man. American Journal of Epidemiology. 1975; 102:30-41.
  62. Wyborney VJ, Pappagianis D, Steelquist J. Bronchogluteal fistula in coccidioidomycosis. Annals of Internal Medicine. 1974; 81:401-402.
  63. Chaparas SD, Levine HB, Pappagianis D, Scalarone G. Comparison of skin reactivity of spherule and mycelial coccidioidins produced by different strains of Coccidioides immitis (37899). Proceedings of the Society for Experimental Biology and Medicine. 1974; 145:806-810.
  64. Werner SB, Pappagianis D. Coccidioidomycosis in Northern California; an outbreak among archeology students near Red Bluff. California Medicine. 1973; 119:16-20.
  65. Chick EW, Baum GL, Furcolow ML, Huppert M, Kaufman L, Pappagianis D. The use of skin tests and serologic tests in histoplasmosis, coccidioidomycosis, and blastomycosis, 1973. American Review of Respiratory Disease. 1973; 108:156-159.
  66. Werner SB, Pappagianis D, Heindl I, Mickel A. An epidemic of coccidioidomycosis among archeology students in Northern California. New England Journal of Medicine. 1972; 286:507-512.
  67. Goldstein E, Winship MJ, Pappagianis D. Ventricular fluid and the management of coccidioidal meningitis. Annals of Internal Medicine. 1972; 77:243-246.
  68. Loofbourow FC, Pappagianis D. Coccidioidomycosis--An occupational hazard for archaeologists. Society for California Archaeology Special Report No. 2, December 1971.
  69. Levine HB, Pappagianis D, Cobb JM. Development of vaccines for coccidioidomycosis. Mycopathologia et Mycologia Applicata. 1970; 41:177-185.
  70. Zweiman B, Pappagianis D, Maibach H, Hildreth E. Coccidioidin delayed hypersensitivity: skin test and in vitro lymphocyte reactivities. Journal of Immunology. 1969; 105:1284-1289.
  71. Loofbourow J, Pappagianis D, Cooper T. Endemic coccidioidomycosis in Northern California. An outbreak in the Capay Valley of Yolo County. California Medicine. 1969; 111:5-9.
  72. Pappagianis D, Maibach H, Smith CE. Microscopic characteristics of the cutaneous reaction to coccidioidin in humans. American Review of Respiratory Disease. 1967; 95:317-319.
  73. Pappagianis D, Smith CE, Campbell CC. Serologic status following positive coccidioidin skin test. American Review of Respiratory Diseases. 1967; 96:520-523.
  74. Pappagianis D. Histopathologic response of mice to killed vaccine of Coccidioides immitis. Journal of Investigative Dermatology. 1967; 49:71-77.
  75. Smith CE, Pappagianis D, Levine HB, Saito M. Human coccidioidomycosis. Bacteriological Review. 1961; 25:310-320.
  76. Pappagianis D, Levine HB, Smith CE, Berman RJ, Kobayashi GS. Immunization of mice with viable Coccidioides immitis. Journal of Immunology. 1961; 86:28-34.
  77. Pappagianis D. Active immunity in coccidioidomycosis: Natural and laboratory features. Stanford Medical Bulletin. 1961; 19:35-40.
  78. Pappagianis D, Smith CE, Berman RJ, Kobayashi GS. Experimental subcutaneous coccidioidal infection in the mouse. Journal of Investigative Dermatology. 1959; 32:589-598.
  79. Rapaport FT, Lawrence HS, Millar JW, Pappagianis D, Smith CE. Transfer of delayed hypersensitivity to coccidioidin in man. Journal of Immunology. 1960; 84:358-367.
  80. Smith CE, Pappagianis D, Saito MT. The public health significance of coccidioidomycosis. United States Public Health Service Publication. 1957; 575:3-9.

Veterinary Studies of Coccidioidomycosis

  1. Vishkautsan P, Papich MG, Thompson GR III, Sykes JE. Pharmacokinetics of voriconazole after intravenous and oral administration to healthy cats. American Journal of Veterinary Research. 2016 Sep;77(9):931-9. PMID: 27580104
  2. Mehrkens L, Mohr C, Sykes JE. Clinicopathologic and histopathologic renal abnormalities in dogs with coccidioidomycosis. Journal of Veterinary Internal Medicine. 2017; 30(5): 1667-1671.
  3. Grayzel S, Martinez-Lopez B, Sykes JE. Risk factors and spatial distribution of canine coccidioidomycosis in California, 2005-2013. Transboundary and Emerging Diseases. 2017; 64(4): 1110-1119.
  4. Huckabone SE, Gulland FM, Johnson SM, Colegrove KM, Dodd EM, Pappagianis D, Dunkin RC, Casper D, Carlson EL, Sykes JE, Meyer W, Miller MA. Coccidioidomycosis and other systemic mycoses of marine mammals stranding along the central California, USA coast: 1998-2012. J. Wildl. Dis. 2015, 51(2):295-308.
  5. Catalán-Dibene J, Johnson SM, Eaton R, Romero-Olivares AL, Baptista-Rosas RC, Pappagianis D, Riquelme M. Detection of coccidioidal antibodies in serum of a small rodent community in Baja California, Mexico. Fungal Biol., 2014 118(3):330-339.
  6. Diab S, Johnson SM, Garcia J, Carlson EL, Pappagianis D, Smith J, Uzal FA. Case report: abortion and disseminated infection by Coccidioides posadasii in an alpaca (Vicugna pacos) fetus in Southern California. Med. Mycol. Case, 2013 2:159-62.
  7. Higgins, J.C, Leith, G.S., Pappagianis, D. Pusterla, N. 2006. Treatment of Coccicioides immitis pneumonia. Veterinary Record. 2006 139:349-351.
  8. Higgins J.C., G.T. Leith, E.D., Voss, Pappagianis D. Seroprevalence of antibodies against Coccidioides immitis in healthy horses. J. Amer. Vet Med Assoc. 2005 226:1888-1892.
  9. Higgins, J.C., Pusterla, N., Pappagianis, D. Comparison of Coccicioides immitis serological antibody titers between forms of clinical coccidioidomycosis in horses. The Veterinary Journal. 2005 173(1): 118-23.
  10. Johnson LR, Herrgesell EJ, Davidson AM, Pappagianis D. Clinical, clinicopathologic, and radiographic findings in dogs with coccidioidomycosis: 24 cases (1995-2000). JAVMA. 2003 222:461-466.
  11. Maleski K, Magdesian KG, LaFranco-Scheuch L, Pappagianis D, Carlson GP. Pulmonary coccidioidomycosis in a neonatal foal. Vet. Record. 2002 151:505-508.
  12. Reidarson TH, Griner LA, Pappagianis D, McBain J. Coccidioidomycosis in a Bottlenose Dolphin. Journal of Wildlife Diseases. 1998 34:629-631.
  13. Mathews KG, Davidson AP, Koblik PD, Richardson EF, Komtebedde J, Pappagianis D, Hector RF, Kass PH. Comparison of topical administration of clotrimazole through surgically placed versus nonsurgically placed catheters for treatment of nasal aspergillosis in dogs: 60 cases (1990-1996). Journal American Veterinary Medical Association. 1998 213:501-506.
  14. Durry E, Pappagianis, D, Werner SB, Hutwagner L, Sun RK, Maurer M, McNeil MM, Pinner RW. Coccidioidomycosis in Tulare County, California, 1991: reemergence of an endemic disease. Journal of Medical and Veterinary Mycology. 1997 35:321-326.
  15. Davidson, A., and Pappagianis, D. Canine Coccidioidomycosis: 1970-1993, p. 155-162, In H. Einstein and A Cantanzaro (eds), Proceedings of the 5th Centennial Conference on Coccidioidomycosis. National Foundation for Infectious Diseases, Bethesda, MD. 1996
  16. Mathews KG, Koblik PD, Richardson EF, Davidson AF, Pappagianis D. Computed tomographic assessment of noninvasive intranasal infusions in dogs with fungal rhinitis. Veterinary Surgery. 1996, 25:309-319.
  17. Walker RL, Johnson BJ, Jones KL, Pappagianis D, Carlson GP. Coccidioides immitis mastitis in a mare. Journal of Veterinary Diagnostic Investigation. 1993, 5:446-448.
  18. Fowler ME, Pappagianis D, Ingram I. Coccidioidomycosis in llamas in the United States: 19 cases (1981-1989). Journal of American Veterinary Medical Association. 1992, 201:1609-1614.
  19. Ziemer EL, Pappagianis D, Madigan JE, Mansmann RA, Hoffman KD. Coccidioidomycosis in horses: 15 cases (1975-1984). Journal of the American Veterinary Medical Association. 1992, 201:910-916.
  20. Muir S, Pappagianis D. Coccidioidomycosis in the llama: Case report and epidemiologic survey. Journal of the American Veterinary Medical Association. 1982; 181:1334-1337.
  21. Wolf AM, Pappagianis D. Canine coccidioidomycosis - treatment with a new antifungal agent: ketoconazole. California Veterinarian. 1981; 35:25-28
  22. Shifrine M, Pappagianis D, Neves J. Double electroimmunodiffusion: A rapid diagnostic test for canine coccidioidomycosis. American Journal of Veterinary Research. 1975; 36:819-820.
  23. Pappagianis D, Vanderlip J, May B. Coccidioidomycosis naturally acquired by a monkey, Cercocebus atys. Sabouraudia. 1973; 11:52-55.
  24. Pappagianis D, Miller RL, Smith CE, Kobayashi GS. Response of monkeys to respiratory challenge following subcutaneous inoculation with Coccidioides immitis. American Review of Respiratory Diseases. 1960; 82:244-250.

Epidemiology, Ecology, and Evolutionary Biology

  1. Stewart ER, Thompson GR III. Update on the Epidemiology of Coccidioidomycosis. Current Fungal Infection Reports. 2016 Oct 10:141-146.
  2. Engelthaler DM, Roe CC, Hepp, CM, Teixeira M, Driebe EM, Schupp JM, Gade L, Waddell V, Komatsu K, Arathoon E, Logemann H, Thompson GR III, Chiller T, Barker B, Litvintseva AP, Keim P. Coccidioides whole population genome SNP analysis reveals local population structure and patterns of hemispheric dispersal. Manuscript accepted for publication to mBio. 2016 Apr 26;7(2):e00550-16. PMID: 27118594
  3. Benedict K, Thompson GR III, Deresinski S, Chiller T. Mycotic Infections Acquired outside Areas of Known Endemicity, United States. Emerging Infectious Diseases. 2015 Nov;21(11):1935-41. PMID: 26485441
  4. Litvintseva AP, Marsden-Haug N, Hurst S, Hill H, Gade L, Engelthaler DM, Driebe E, Roe C, Keim P, Ralston C, Wohrle R, Goldoft M, Thompson GR III, Chiller T, Brandt M. Valley Fever: Finding new places for an old disease: Coccidioides immitis found in Washington State soil associated with recent human infection. Clinical Infectious Diseases. 2015 Jan 1;60(1):e1-3. PMID: 25165087
  5. Marsden-Haug N, Hill H, Litvintseva AP, Engelthaler D, Driebe EM, Roe CC, Ralston C, Hurst S, Goldoft M, Gade L, Wohrle R, Thompson GR III, Brandt M, Chiller T, Washington State Department of Health. Notes from the Field: Coccidioides immitis Identified in Soil Outside of Its Known Range - Washington, 2013. MMWR Morbidity and Mortality Weekly Report. 2014 May 23;63(20):450. PMID: 24848217
  6. Johnson SM, Carlson EL, Fisher FS, Pappagianis D. Demonstration of Coccidioides immitis and Coccidioides posadasii DNA in soil samples collected from Dinosaur National Monument, Utah. Med. Mycol. 2014 52(6):610-7.
  7. Brown J, Benedict K, Park BJ, Thompson GR III. Coccidioidomycosis: epidemiology. Clinical Epidemiology. 2013 Jun 25;5:185-97. PMID: 23843703
  8. Fisher FS, Bultman MW, Johnson SM, Pappagianis D, Zaborsky E. Coccidioides niches and habitat parameters in the southeastern United States: a matter of scale. Ann NY Acad Sci, 2007 1111:47-72
  9. Pappagianis D. Marked increase in cases of coccidioidomycosis in California: 1991, 1992, and 1993. Clinical Infectious Diseases. 1994, 19(Suppl. 1):S14-18.
  10. Pappagianis D, Einstein H. Tempest from Tehachapi takes toll or Coccidioides conveyed aloft and afar. Western Journal of Medicine. 1978; 129:527-530.
  11. Pappagianis D. Epidemiological aspects of respiratory mycotic infections. Bacteriological Reviews. 1967; 31:25-34.
  12. Hoggan MD, Ransom JP, Pappagianis D, Donald GE, Bell AD. Isolation of Coccidioides immitis from the air. Stanford Medical Bulletin. 1956; 14:190.

Diagnostic Testing

  1. Thompson GR III, Sharma S, Bays DJ, Pruitt R, Engelthaler DM, Bowers J, Driebe EM, Davis M, Libke R, Cohen SH, Pappagianis D. Pleural Effusions Caused by Coccidioidomycosis: ADA levels, serologic parameters, culture results and PCR testing. CHEST. 2013 Mar;143(3):776-81. PMID: 23187746
  2. Thompson GR III, Bays DJ, Johnson SM, Cohen SH, Pappagianis D, Finkelman MA. D. Serum (1®3)-β-D-Glucan Measurement in Coccidioidomycosis. Journal of Clinical Microbiology. 2012 Sep;50(9):3060-2. PMID: 22692738
  3. Kuberski T, Herrig J, Pappagianis D. False positive IgM Serology in coccidioidomycosis. Journal of Clinical Micro. 2010; 48:2047-2049.
  4. Johnson, S.M., K.A. Simmons, Pappagianis D. Amplification of coccidioidal DNA in clinical specimens by PCR. Journal of Clinical Microbiology. 2004; 42:1982-1985.
  5. Pappagianis D. Serologic studies in Coccidioidomycosis. Seminars in Respiratory Infections. 2001; 16:242-250.
  6. Pappagianis, D. Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities. Fungal Genetics and Biology. 2001; 32:1-9
  7. Pappagianis D. Coccidioides immitis Antigen. Journal of Infectious Diseases. 1999 180:243-244.
  8. Pappagianis D. Serology of Coccidioidomycosis, p. 33-35, In H. Einstein and A Cantanzaro (eds), Proceedings of the 5th Centennial Conference on Coccidioidomycosis. National Foundation for Infectious Diseases, Bethesda, MD. 1996
  9. Zimmermann CR, Johnson SM, Martens GW, White AG, Pappagianis D. Cloning and expression of the complement fixation antigen-chitinase of Coccidioides immitis. Infection and Immunity. 1996; 64:4967-4975.
  10. Johnson SM, Zimmermann CR, Pappagianis D. Use of a recombinant Coccidioides immitis complement fixation antigen-chitinase in conventional serological assays. Journal of Clinical Microbiology. 1996, 34:3160-3164.
  11. Galgiani J, Peng T, Lewis ML, Cloud GA, Pappagianis D. and the National Institute of Allergy and Infectious Diseases Mycoses Study Group. Cerebrospinal fluid antibodies detected by ELISA against a 33-kDa antigen from spherules of Coccidioides immitis in patients with coccidioidal meningitis. Journal of Infectious Diseases. 1996, 173:499-502.
  12. Kaufman L, Sekhon AS, Moledina N, Jalbert M, Pappagianis D. Comparative evaluation of commercial premier EIA and microimmunodiffusion and complement fixation tests for Coccidioides immitis antibodies. Journal of Clinical Microbiology. 1995, 33:618-619.
  13. Johnson SM, Zimmermann CR, Pappagianis D. Amino-terminal sequence analysis of the Coccidioides immitis chitinase/immunodiffusion-complement fixation protein. Infection and Immunity. 1993, 61:3090-3092.
  14. Johnson SM, Pappagianis D. The coccidioidal complement fixation and immunodiffusion-complement fixation antigen is a chitinase. Infection and Immunity. 1992, 60:2588-2592.
  15. Pappagianis D, immer BL. Serology of Coccidioidomyosis. Clinical Microbiology Reviews. 1990; 3:247-268.
  16. Resnick S, Zimmer B, Pappagianis D, Eakin A, McKerrow J. Purification and amino-terminal sequence analysis of the complement-fixing and precipitin antigens from Coccidioides immitis. Journal of Clinical Microbiology. 1990; 28:385-388.
  17. Zimmer BL, Pappagianis D. Immunoaffinity isolation and partial characterization of the Coccidioides immitis antigen detected by the tube precipitin and immunodiffusion-tube precipitin tests. Journal of Clinical Microbiology. 1989; 27:1759-1766.
  18. Zimmer BL, Pappagianis D. Characterization of a soluble protein of Coccidioides immitis with activity as an immunodiffusion-complement fixation antigen. Journal of Clinical Microbiology. 1988; 26:2250-2256.
  19. Kaufman L, Standard PG, Huppert M, Pappagianis D. Comparison and diagnostic value of the coccidioidin heat-stable (HS and tube precipitin) antigens in immunodiffusion. Journal of Clinical Microbiology. 1985; 22:515-518.
  20. Wieden MA, Galgiani JN, Pappagianis D. Comparison of immunodiffusion techniques with standard complement fixation assay for quantitation of coccidioidal antibodies. Journal of Clinical Microbiology. 1983; 18:529-534.
  21. Aguilar-Torres FG, Rytel MW, Pappagianis D, Jackson L. Counterimmunoelectrophoresis as a rapid screening test in coccidioidomycosis. Revista de Investigacion Clinica (Mex.). 1978; 30:247-251.
  22. Pappagianis D, Krasnow I, Beall S. False-positive reactions of cerebrospinal fluid and diluted sera with the coccidioidal latex-agglutination test. American Journal of Clinical Pathology. 1976; 66:916-921.
  23. Aguilar-Torres FG, Jackson LJ, Ferstenfeld JE, Pappagianis D, Rytel MW. Counterimmunoelectrophoresis in the detection of antibodies against Coccidioides immitis. Annals of Internal Medicine. 1976; 85:740-744.
  24. Scalarone GM, Levine HB, Pappagianis D, Chaparas SD. Spherulin as a complement-fixing antigen in human coccidioidomycosis. American Review of Respiratory Diseases. 1974; 110:324-328.
  25. Pappagianis D, Saito M, Hoosear KV. Antibody in the cerebrospinal fluid in non-meningitic coccidioidomycosis. Sabouraudia. 1972; 10:173-179.

Vaccine Development and Immunology

  1. Ampel NM, Nesbit LA, Nguyen CT, Chavez S, Knox KS, Johnson SM, Pappagianis D. Cytokine Profiles from Antigen-Stimulated Whole-Blood Samples among Patients with Pulmonary or Nonmeningeal Disseminated Coccidioidomycosis. Clin. Vaccine Immunol. 2015 22(8):917-22.
  2. Nesbit LA, Knox KS, Nguyen CT, Roesch J, Wheat LJ, Johnson SM, Pappagianis D, Chavez S, Ampel NM. Immunological characterization of bronchoalveolar lavage fluid in patients with acute pulmonary coccidioidomycosis. J. Infect Dis. 2013; 208(5):857-63.
  3. Nesbit L., Johnson SM, Pappagianis D, Ampel NM. Polyfunctional T lymphocytes are in the peripheral blood of donors naturally immune to coccidioidomycosis and are not induced by dendritic cells. Infection and Immunity. 2010; 78(1):309-15.
  4. Johnson SM, Kerekes KM, Lunetta JM, Pappagianis D. Characteristics of the protective subcellular coccidioidal T27K vaccine. Ann NY Acad Sci. 2007; Sep, 1111-:275-89.
  5. Johnson SM, Lerche NW, Pappagianis D, Yee JL, Galgian JN, Hector RF. Safety, antigenicity, and efficacy of a recombinant coccidioidomycosis vaccine in cynomolgus macaques (Maca fascicularis). Ann NY Acad Sci, 2007; 1111:290-300.
  6. Ampel N. M., Nelson D. K., Li L., Dionne S. O., Lake D. F., Simmons K. A. Pappagianis D. The mannose receptor mediates the cellular immune response in human coccidioidomycosis. Infection and Immunity. 2005 73(4):2554-5.
  7. Ampel, N.M., Nelson, D.K. Chavez, S., Naus, K.A., Herman, A.B., Li L., Simmons, K.A., Pappagianis, D. Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis. Clin Diagn Lab Immunol. 2005 Jun:12(6):700-4.
  8. Ampel NM, Kramer KA, Li L, Carroll DS, Kerekes KM, Johnson SM, Pappagianis D. In vitro whole blood analysis of cellular immunity in patients with active coccidioidomycosis by using the antigen preparation T27K. Clin Diagn Lab Immunol. 2002 9(5):1039-43.
  9. Ampel NM, Kramer LA, Kerekes KM, Johnson SM, Pappagianis D. Assessment of the human cellular immune response to T27K, a coccidioidal antigen preparation, by flow cytometry of whole blood. Medical Mycology. 2001 39: 315-320.
  10. Zimmermann CR, Johnson SM, Martens GW, White AG, Zimmer BL, Pappagianis D. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules. Infection and Immunity. 1998 66:2342-2345.
  11. Pappagianis, D., and the Valley Fever Vaccine Study Group. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. American Review of Respiratory Disease. 1993, 148:656-660.
  12. Castaneda E, Brummer E, Pappagianis D, Stevens DA. Regulation of immune responses by T suppressor cells and by serum in chronic paracoccidioidomycosis. Cellular Immunology. 1988; 117:1-11.
  13. Castaneda E, Brummer E, Pappagianis D, Stevens DA. Impairment of cellular but not humoral immune responses in chronic pulmonary and disseminated paracoccidioidomycosis in mice. Infection and Immunity. 1988; 56:1771-1777.
  14. Williams PL, Sable DL, Sorgen SP, Pappagianis D, Levine HB, Brodine SK, Brown BW, Grumet FC, Stevens DA. Immunologic responsiveness and safety associated with the Coccidioides immitis spherule vaccine in volunteers of White, Black, and Filipino ancestry. American Journal of Epidemiology. 1984; 119:591-602.
  15. Beaman L, Benjamini E, Pappagianis D. Activation of macrophages by lymphokines: enhancement of phagosome-lysosome fusion and killing of Coccidioides immitis. Infection and Immunity. 1983; 39:1201-1207.
  16. Beaman L, Benjamini E, Pappagianis D. Role of lymphocytes in macrophage-induced killing of Coccidioides immitis in vitro. Infection and Immunity. 1981; 34:347-353.
  17. Beaman L, Pappagianis D, Benjamini E. Mechanisms of resistance to infection with Coccidioides immitis in mice. Infection and Immunity. 1979; 23:681-685.
  18. Pappagianis D, Hector R, Levine HB, Collins MS. Immunization of mice against coccidioidomycosis with a subcellular vaccine. Infection and Immunity. 1979; 25:440-445.
  19. Beaman L, Pappagianis D, Benjamini E. Significance of T cells in resistance to experimental murine coccidioidomycosis. Infection and Immunity. 1977; 17:580-585.
  20. Danley DL, Pappagianis D, Benjamini E. In vitro hemolysis of autologous erythrocytes caused by immune murine spleen cells and spherules of the fungus Coccidioides immitis. Journal of Immunology. 1976; 116:970-975.
  21. Stevens DA, Pappagianis D, Marinkovich VA, Waddell TF. Immunotherapy in recurrent coccidioidomycosis. Cell. Immunol. 1974;12:37-48.
  22. Ibrahim AB, Pappagianis D. Experimental induction of anergy to coccidioidin by antigens of Coccidioides immitis. Infection and Immunity. 1973; 7:786-794.
  23. Rapaport FT, Lawrence HS, Millar JW, Pappagianis D, Smith CE. The immunologic properties of coccidioidin as a skin test regent in man. Journal of Immunology. 1960; 84:368-373.

Basic Microbiology

  1. Lee CY, Thompson GR III, Hastey C, Hodge GC, Lunetta JM, Pappagianis D, Heinrich V. Single-cell recognition of Coccidioides by human neutrophils and comparison with other fungi and model pathogens. PLoS One. 2015 Jun 12;10(6):e0129522. PMID: 26070210 *Featured in Faculty of 1000
  2. Johnson SM, Carlson EL, Pappagianis D. Coccidioides species determination: does sequence analysis agree with restriction fragment length polymorphism? Mycopathologia, 2015 179(5-6):373-9.
  3. Johnson SM, Carlson EL, Pappagianis D. Determination of ribosomal DNA copy number and comparison among strains of Coccidioides. Mycopathologia, 2015 179(1-2):45-51.
  4. Lunetta JM, Pappagianis D. Identification, molecular characterization, and expression analysis of a DOMON-like type 9 carbohydrate-binding module domain-containing protein of Coccidioides posadasii. 2014 Med. Mycol., 52(6):591-609.
  5. Lunetta JM, Johnson SM, Pappagianis D. Molecular cloning, characterization and expression analysis of two beta-N-acetylhexosaminidase homologs of Coccidioides posadasii. Medical Mycology. 2010 48(5):44-56.
  6. Lunetta JM, Simmons KA, Johnson SM, Pappagianis D. Molecular cloning and expression of a cDNA encoding a Coccidiodes posadasii 1,2-alpha-mannosidase identified in the coccidioidal T27K vaccine by immunoproteomic methods. Ann NY Acad Sci, 2007. 1111:164-80.
  7. Lunetta JM, Simons KA, Johnson SM, Pappagianis D. Molecular cloning and expression of a cDNA encoding a Coccidioides posadasii Cu,Zn superoxide dismutase identified by proteomic analysis of the coccidioidal T27K vaccine. Ann NY Acad Sci, 1111:181-87.
  8. Friedman, L., D. Pappagianis, R.J. Berman and C.E. Smith. Studies on Coccidioides immitis: Morphology and sporulation capacity of forty-seven strains. Journal of Laboratory and Clinical Medicine. 1953.42:438-444.
  9. Kamberi, P., R.A. Sobel, K.V. Clemons, D.A. Stevens, D. Pappagianis and P.L. Williams. A murine model of coccidioidal meningitis. The Journal of Infectious Diseases. 2003 187:453-460.
  10. Johnson SM, Kerekes KM, Zimmermann CR, Williams RH, Pappagianis D. Identification and cloning of an aspartyl proteinase from Coccidioides immitis. GENE 2000 241:213-222.
  11. Johnson, S., Williams, R., Martens, G., and Pappagianis, D. Alkaline phosphatase activity of Coccidioides immitis, p.174-182, In H. Einstein and A Cantanzaro (eds), Proceedings of the 5th Centennial Conference on Coccidioidomycosis. National Foundation for Infectious Diseases, Bethesda, MD.1996
  12. Zimmermann CR, Snedker CJ, Pappagianis D. Characterization of Coccidioides immitis isolates by restriction fragment length polymorphisms. Journal of Clinical Microbiology. 1994, 32:3040-3042.
  13. Resnick S, Pappagianis D, McKerrow JH. Proteinase production by the parasitic cycle of the pathogenic fungus Coccidioides immitis. Infection and Immunity. 1987; 55:2807-2815.
  14. Zimmer BL, Pappagianis D. Comparison of immunoblot analyses of spherule-endospore-phase extracellular protein and mycelial phase antigen of Coccidioides immitis. Infection and Immunity. 1986; 53:64-70.
  15. Pappagianis D, Ornelas A, Hector R. Guanine plus cytosine content of the DNA of Coccidioides immitis. Sabouraudia: Journal of Medical and Veterinary Mycology. 1985; 23:451-454.
  16. Hector RF, Pappagianis D. Inhibition of chitin synthesis in the cell wall of Coccidioides immitis by polyoxin D. Journal of Bacteriology. 1983; 154:488-498.
  17. Hector RF, Pappagianis D. Enzymatic degradation of the walls of spherules of Coccidioides immitis. Experimental Mycology. 1982; 6:136-152.
  18. Collins MS, Pappagianis D. Inhibition by lysozyme of growth of the spherule phase of Coccidioides immitis in vitro. Infection and Immunity. 1974; 10:616-623.
  19. Collins M, Pappagianis D. The effects of lysozyme and chitinase on the spherules of C. immitis in vitro. Infection and Immunity. 1973; 7:817-822.
  20. Kobayashi G, Pappagianis D. Preparation and standardization of antigens of Histoplasma capsulatum and Coccidioides immitis. Mycopathologia. 1970; 41:139-153.
  21. Pappagianis D, Putman EW, Kobayashi GS. Polysaccharide of Coccidioides immitis. Journal of Bacteriology. 1961; 32:714-723.
  22. Pappagianis D, Smith CE, Kobayashi GS, Saito MT. Studies of antigens from young mycelia of Coccidioides immitis. Journal of Infectious Diseases. 1961; 108:35-44.
  23. Pappagianis D, Kobayashi GS. Approaches to the physiology of Coccidioides immitis. Annals of the New York Academy of Sciences. 1960; 89:109-121.
  24. Pappagianis D, Smith CE, Saito MT, Kobayashi GS. Preparation and property of a complement-fixing antigen from mycelia of Coccidioides immitis. United States Public Health Service Publication. 1957; 575:57-63.
  25. Pappagianis D, Kobayashi GS. Production of extracellular polysaccharide in cultures of Coccidioides immitis. Mycologia. 1958; 50:229-238.
  26. Pappagianis D, Smith CE, Kobayashi GS. Relationship of the in vivo form of Coccidioides immitis to virulence. Journal of Infectious Diseases. 1956; 98:312-319.
  27. Friedman L, Pappagianis D. The inhibitory effect of peptone on the sporulation of three strains of Coccidioides immitis. American Review of Tuberculosis and Pulmonary Diseases. 1956; 74:147-148.
  28. Friedman L, Smith CE, Pappagianis D, Berman RJ. Survival of Coccidioides immitis under controlled conditions of temperature and humidity. American Journal of Public Health. 1956; 46:1317-1324.
  29. Friedman L, Pappagianis D, Berman RJ, Smith CE. Studies on Coccidioides immitis: Morphology and sporulation capacity of forty-seven strains. Journal of Laboratory and Clinical Medicine. 1953; 42:438-444.

Work on other fungal pathogens

  1. Kullberg BJ, Viscoli C, Pappas PG, Vazquez J, Ostrosky–Zeichner L, Rotstein C, Sobel JD, Herbrecht R, Rahav G, Chetchotisakd P, Wijngaerden EV, Waele JD, Lademacher C, Engelhardt M, Kovanda L, Croos-Dabrera R, Fredericks C, Thompson GR III. Isavuconazole versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial. Manuscript under review.
  2. Roe CR, Bowers J, Oltean H, DeBess E, Dufresne PJ, McBurney S, Overy DP, Wanke B, Lysen C, Chiller T, Meyer W, Thompson GR III, Lockhart SR, Hepp C, Engelthaler DM. Dating the Cryptococcus gattii dispersal to the North American Pacific Northwest. Manuscript accepted for publication. mSphere
  3. Revankar SG, Baddley JW, Chen SCA, Kauffman CA, Slavin M, Vazquez JA, Seas C, Morris MI, Nguyen MH, Shoham S, Thompson GR III, Alexander BD, Simkins J, Ostrosky-Zeichner L, Mullane K, Alangaden G, Andes DR, Cornely OA, Wahlers K, Lockhart SR, Pappas PG. A Mycoses Study Group international prospective study of phaeohyphomycosis: an analysis of 99 proven/probable cases. Accepted for publication. Open Forum Infectious Diseases.
  4. Vu K, Thompson GR III, Roe CC, Sykes JE, Dreibe EM, Lockhart SR, Meyer W, Engelthaler DM, Gelli A. Flucytosine resistance in two Cryptococcus gattii clinical isolates is indirectly mediated by the FCY2-FCY1-FUR1 pathway. Manuscript under review.
  5. Magro M, Sykes J, Vishkautsan P, Martinez-Lopez B. Spatial patterns and impacts of environmental and climatic factors on canine sinonasal aspergillosis in northern California. Frontiers in Veterinary Science. 2017; 4: 104.
  6. Clancy CJ, Pappas PG, Vazquez J, Judson MA, Kontoyiannis DP, Thompson GR III, Garey KW, Reboli A, Greenberg RN, Apewokin S, Marshall Lyon G, Ostrosky-Zeichner L, Wu AHB, Tobin E, Nguyen MH, Caliendo AM. Detecting Infections Rapidly and Easily for Candidemia Trial-Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel. Accepted for Publication. Clinical Infectious Diseases.
  7. Sykes JE, Hodge G, Gelli A, Yang ML, Thompson GR III. In vivo Development of Fluconazole Heteroresistance in Cryptococcus gattii. Medical Mycology. 2017 Jun 1;55(4):396-401. PMID: 28339594
  8. Ferreira-Paim K, Andrade-Silva L, Fonseca FM, Ferreira TB, Mora DJ, Andrade-Silva J, Khan A, Dao A, Reis EC, Almeida MTG, Maltos A, Rodrigues V, Trilles L, Rickerts, Chindamporn VA, Sykes JE, Cogliati M, Nielsen K, Boekhout T, Fisher M, Kwon-Chung J, Engelthaler DM, Lazéra M, Meyer W, Silva-Vergara ML. MLST-based population genetic analysis in a global context reveals clonality amongst Cryptococcus neoformans var. grubii VNI isolates from HIV patients in southeastern Brazil. PLOS Neglected Tropical Diseases. 2017; 11(1): e0005223.
  9. Smith KM, Strom AR, Gilmour MA, LaDouceur E, Reilly CM, Byrne BA, Affolter VK, Sykes JE, Maggs DJ. Utility of antigen testing for the diagnosis of ocular histoplasmosis in four cats: a case series and literature review. Journal of Feline Medicine & Surgery. 2017; 19(10): 1110-1118.
  10. Stewart ER, Thompson GR III. Treatment of Primary Pulmonary Aspergillosis: An assessment of the evidence. Journal of Fungi. 2016 2(25):1-9.
  11. Patterson TF, Thompson GR III, Denning D, Fishman F, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young J, Bennett JE. Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2016 Aug 15;63(4):433-42. PMID: 27481947
  12. Patterson TF, Thompson GR III, Denning D, Fishman F, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young J, Bennett JE. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. PMID: 27365388
  13. Donnelley MA, Zhu ES, Thompson GR III. Isavuconazole in the Treatment of Invasive Aspergillosis and Mucormycosis Infections. Infection and Drug Resistance. 2016 Jun 2;9:79-86. PMID: 27330318
  14. Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR III, Alangaden GJ, Brown JM, Fredricks JN, Heinz WJ, Herbrecht R, Klimko N, Klyasova G, Maertens JA, Melinkeri SR, Oren I, Pappas PG, Ráčil Z, Rahav G, Santos R, Schwartz S, Vehreschild J, Young JH, Chetchotisakd P, Jaruratanasirikul S, Kanj SS, Engelhardt M, Kaufhold A, Ito M, Lee M, Sasse C, Maher R, Zeiher B, Vehreschild MJGT, for the VITAL and FungiScopeä Mucormycosis Investigators. Isavuconazole Treatment for Mucormycosis. The Lancet Infectious Disease. 2016 Jul;16(7):828-37. PMID: 26969258
  15. Cadena J, Thompson GR III, Patterson TF. Invasive Aspergillosis: Current Strategies for Diagnosis and Management. Infectious Disease Clinics of North America. 2016 Mar;30(1):125-42. PMID: 26897064
  16. Maertens JA, Raad I, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz W, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Supparatpinyo K, Thompson GR III, Lee M, Maher R, Schmitt-Hofmann AH, Zeiher B, Ullmann AJ. Isavuconazole versus Voriconazole for Primary Treatment of Invasive Mold Disease Caused by Aspergillus and Other Filamentous Fungi (The SECURE study). Lancet. 2016 Feb 20;387(10020):760-9. PMID: 26684607
  17. Firacative C, Roe CC, Malik R, Ferreira-Paim K, Escandón P, Sykes JE, Castañón-Olivares LR, Contreras-Peres C, Samayoa B, Sorrell TC, Castañeda E, Lockhart SR, Engelthaler DM, Meyer W. MLST and Whole-Genome-based Population Analysis of Cryptococcus gattii VGIII links Clinical, Veterinary and Environmental Strains, and Reveals Divergent Serotype Specific Sub-Populations and Distant Ancestors. PLoS Neglected Tropical Diseases. 2016; 10(8): e0004861.
  18. Yang ML, Uhrig J, Vu K, Singapuri A, Dennis M, Gelli A, Thompson GR III. Fluconazole Susceptibility in Cryptococcus gattii is dependent on the ATP binding cassette (ABC) Transporter PDR11. Antimicrobial Agents and Chemotherapy. 2015 Dec 7;60(3):1202-7. PMID: 26643330
  19. Stewart E, Waldman S, Sutton DA, Sanders C, Lindner J, Fan H, Wiederhold NP, Thompson GR III. Ustilago echinata as a cause of Traumatic Osteomyelitis. Mycopathologia. 2016 Apr;181(3-4):311-4. PMID: 26590580
  20. Espinel-Ingroff A, Chowdhary A, Gonzalez GM, Guinea J, Hagen F, Meis J, Thompson GR III, Turnidge J. Isavuconazole MIC Distributions and Epidemiological Cutoff Values for the Cryptococcus neoformans-Cryptococcus gattii complex by the CLSI Broth Microdilution Method (M27-A3 document): A Multicenter Study. Antimicrobial Agents and Chemotherapy. 2014. Epub ahead of print. PMID: 25313209
  21. Eldridge M, Chambers CJ, Sharon VR, Thompson GR III. Fungal infections of the skin and nail: new treatment options. Expert Review of Anti-infective Therapy. 2014 Nov;12(11):1389-405. PMID: 25241767
  22. Engelthaler DM, Hicks N, Gillece J, Roe C, Schupp JM, Driebe EM, Gilgado F, Carriconde F, Trilles L, Firacative C, Ngamskulrungroj P, Castaneda E, Lazera MDS, Melhem M, Perez-Bercoff A, Huttlley G, Sorrell T, Voelz K, My RC, Fisher M, Thompson GR III, Lockhart S, Keim P, Meyer W. Cryptococcus gattii in North American Pacific Northwest: whole population genome analysis provides insights into species evolution and dispersal. mBio. 2014 Jul 15;5(4). PMID: 25028429
  23. Vu K, Tham R, Uhrig JP, Thompson GR III, Na Pombejra S, Jamklnag M, Mautos JM, Gelli A. Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloprotease. mBio. 2014 Jun 3;5(3):e01101-14. PMID: 24895304
    *IDWeek 2012TM Program Committee Choice Award - given to the four best accepted abstracts overall at IDWeek - 50th Annual Infectious Diseases Society of America (IDSA) Meeting. San Diego, CA: 2012. *Featured in Faculty of 1000
  24. Thompson GR III, Albert N, Hodge G, Wilson MD, Sykes JE, Bays DJ, Firacative C, Meyer W, Kontoyiannis DP. Phenotypic Differences of Cryptococcus genotypes: implications for virulence in a Drosophila model of infection. Infection and Immunity. 2014 July;82(7):3058-3065. PMID: 24799631
  25. Singer LM, Meyer W, Firacative C, Thompson GR III, Samitz E, Sykes JE. Antifungal Drug Susceptibility and Phylogenetic Diversity Among Cryptococcus Isolates from Dogs and Cats in North America. Journal of Clinical Microbiology. 2014; Jun;52(6):2061-70. PMID: 24696030
  26. Thompson GR III, Kontoyiannis DP, Patterson TF. Management of an Outbreak: Real-World experience in the midst of an Exserohilum meningitis outbreak. Journal of the American Medical Association (JAMA). 2013; Jun 19;309(23):2493-5. PMID: 23780464
  27. Chang C, Gershwin E, Thompson GR III. Fungal Disease of the Nose and Sinuses: An Updated Overview. Current Allergy and Asthma Reports. 2013 Apr;13(2):152-61. PMID: 23135919
  28. Patel PK, Erlandsen JE, Kirkpatrick WR, Berg DK, Westbrook SD, Thompson GR III, Vallor AC, Redding SW, Patterson TF. The Epidemiology and Significance of Oropharyngeal Candidiasis in Patients with HIV/AIDS in the Era of Antiretroviral Therapy. AIDS Research and Treatment. 2012;2012:262471. PMID: 22970352
  29. Thompson GR III, Wiederhold NP, Najvar LK, Bocanegra R, Kirkpatrick WR, Graybill DR, Patterson TF. A Murine Model of Cryptococcus gattii Meningoencephalitis. Journal of Antimicrobial Chemotherapy. 2012 Jun;67(6):1432-8. PMID: 22378683
  30. Thompson GR III, Patterson TF. Fungal disease of the nose and paranasal sinuses. Journal of Allergy and Clinical Immunology. 2012; Feb; 129(2):321-6. PMID: 22206776
    *Featured in Faculty of 1000
  31. Thompson GR III, Patterson TF. Pulmonary Aspergillosis: Recent Advances. Respiratory and Critical Care Medicine. 2011; Dec;32(6):673-81. PMID: 22167395
  32. Lat A, Bhadelia N, Miko B, Furuya EY, Thompson GR III. Invasive Aspergillosis Following H1N1 Influenza. Emerging Infectious Diseases. 2010; Jun; 16(6):971-3. PMID: 20507748
    *Featured in MedScape; June 2010
  33. Palacio F, Cadena JA, Thompson GR III, Owens AD, Patterson TF. A noninvasive renal fungus ball caused by Rhizopus - a previously unreported manifestation of zygomycosis. Medical Mycology. 2010; Sep; 48(6):866-9. PMID: 20353310
  34. Nierenberg NE, Thompson GR III, Lewis JS II, Hogan BK, Patterson TF. Voriconazole Use and Pharmacokinetics in Combination with Interferon-γ for Refractory Cryptococcal Meningitis in a Patient Receiving Low-Dose Ritonavir. Medical Mycology. 2010 May; 48(3):532-6. PMID: 19835489
  35. Thompson GR III, Patel PK, Erlandsen J, Redding SW, Patterson TF. Oropharyngeal Candidiasis in the Era of Highly Active Antiretroviral Therapy. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 2010; Apr: 109(4):488-95. PMID: 20156694
  36. Lat A, Thompson GR III, Rinaldi MG, Dorsey SA, Pennick G, Lewis JS II. Micafungin Concentrations from Brain Tissue and Pancreatic Pseudocyst Fluid. Antimicrobial Agents and Chemotherapy. 2010; Feb; 54(2):943-4. PMID: 19933794
    *Featured on MDLinx.com; 04 February 2010
  37. Thompson GR III, Cadena J, Patterson TF. Overview of Antifungal Agents. Clinics in Chest Medicine. 2009;30(2):203-15. PMID: 19375628
  38. Cadena J, Thompson GR III, Ho T, Medina E, Hughes D, Patterson TF. Immune Reconstitution Inflammatory Syndrome (IRIS) Following Cessation of the TNF-α Blocker Adalimumab in Cryptococcal Pneumonia. Diagnostic Microbiology and Infectious Diseases. 2009; July; 64(3):327–330. PMID: 19501793
  39. Thompson GR III, Wiederhold NP, Sutton DA, Fothergill AW, Patterson TF. In Vitro Activity of Isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces, and Pichia Species. The Journal of Antimicrobial Chemotherapy. 2009; Jul; 64(1):79-83. PMID: 19406849
  40. Thompson GR III, Rinaldi MG, Pennick G, Dorsey SA, Patterson TF, Lewis JS. Posaconazole Therapeutic Drug Monitoring (TDM) – A Reference Laboratory Experience. Antimicrobial Agents and Chemotherapy. 2009; May; 53(5):2223-4. PMID: 19258264
  41. Thompson GR III, Wiederhold NP, Fothergill AW, Vallor AC, Wickes BL, Patterson TF. Antifungal Susceptibility Among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy. 2009; Jan: 53(1):309-311. PMID: 18955539
  42. Thompson GR III, Patterson TF. Pulmonary Aspergillosis. Seminars in Respiratory and Critical Care Medicine. 2008;29(2):103-10. PMID: 18365992
  43. Thompson GR III, Wiederhold NP, Vallor AC, Villareal NC, Lewis JS 2nd, Patterson TF. Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata. Antimicrobial Agents and Chemotherapy. 2008; Oct;52(10):3783-3785. PMID: 18676885
  44. Thompson GR III, Fothergill AW, Wiederhold NP, Vallor AC, Wickes BL, Patterson TF. Evaluation of Etest Method for Determining Isavuconazole MICs Against Cryptococcus gattii and Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy. 2008; Aug;52(8):2959-61. PMID: 18559645
  45. Morrill, J.F., Heinig, M.J., Pappagianis, D., Dewey, K.G. Risk factors for mammary candidosis among lactating women. J. Obstet Gynecol Neonatal Nurse. 2005 Jan-Feb:34(1): pp. 37-45.
  46. Thompson GR III, LaValle CE, Everett ED. Unusual Manifestations of Histoplasmosis. Diagnostic Microbiology and Infectious Disease. 2004; 50(1):33-41. PMID: 15380276
  47. Morrill, JF, Pappagianis D, Heinig MJ, Lönnerdal B, Dewey KG. Detecting Candida albicans in human milk. Journal of Clinical Microbiology. 2003 41:475-478.
  48. Pappagianis D, Ajello L. Dematiaceous - a mycologic misnomer? Journal of Medical and Veterinary Mycology. 1994, 32:319-321.
  49. Pappagianis D. Coccidioidomycosis. Seminars in Dermatology. 1993, 12:301-309.
  50. Medoff G, Dismukes WE, Pappagianis D, Diamond R, Gallis HA, Drutz D. Evaluation of new antifungal drugs for the treatment of systemic fungal infections. Clinical Infectious Diseases. 1992, 15(Suppl.1):S274-S281.
  51. Tucker RM, Denning DW, Hanson LH, Rinaldi MG, Graybill JR, Sharkey JR, Pappagianis D, Stevens DA. Interaction of azoles with rifampin, phenytoin, and carbamazepine: In vitro and clinical observations. Clinical Infectious Diseases. 1992, 14:165-174.
  52. Pappagianis D. Coccidioidomycosis. Infections in Medicine. 1991; 8:19-26.
  53. Pappagianis D, Collins MS, Hector R, Remington J. Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrobial Agents and Chemotherapy. 1979; 16:123-126.
  54. Collins MS, Pappagianis D. Lysozyme-enhanced killing of Candida albicans and Coccidioides immitis by amphotericin B. Sabouraudia. 1974; 12:329-340.
  55. Pappagianis D. Diagnosis of cryptococcal infections. New England Journal of Medicine. 1966; 275:223.
  56. Pappagianis D, Marovitz R. Studies on ethanol production by Cryptococcus neoformans. Sabouraudia. 1966 4:250-255.
  57. Pappagianis D, Phaff HJ. Delayed fermentation of sucrose by certain haploid species of Saccharomyces. Antonie van Leeuwenhoek. 1956; 22:353-370.
  58. Vaughn RH, Won WD, Spencer FB, Pappagianis D, Foda IO, Krumperman PH. Lactobacillus plantarum, the cause of "Yeast Spots" on olives. Applied Microbiology. 1953; 1:82-85.

Book Chapters in Fungal Diseases

  1. Thompson GR III, Gomez BL. Histoplasma, Blastomyces, Coccidioides and other dimorphic fungi causing systemic mycoses. In: Manual of Clinical Microbiology (ASM Press) 12th Ed. 2019
  2. Thompson GR III, Patterson TF. Aspergillosis. In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases 8th Ed. 2019
  3. Hospenthal DR, Thompson GR III, Oppenheimer AP, Arsura EL. Coccidioidomycosis and Valley Fever. Medscape Reference. Updated 17 July 2017.
  4. Kaufmann CA, Galgiani JN, Thompson GR III. Endemic Mycoses. In: Lee Goldman and Andrew I. Schafer (Eds.) Cecil’s Textbook of Medicine 25th Ed. (pp. TBA) New York, NY: Elsevier Saunders, c2017.
  5. Thompson GR III. Coccidioides immitis and Coccidioides posadasii. In: Long SS, Pickering LK, Prober CG (Eds). Principles and Practice of Pediatric Infectious Diseases 5th Ed. New York: Churchill Livingstone, c2016.
  6. Thompson GR III, Patterson TF. Cryptococcus Species. In: Long SS, Pickering LK, Prober CG (Eds). Principles and Practice of Pediatric Infectious Diseases 5th Ed. New York: Churchill Livingstone, c2016.
  7. Thompson GR III, Gomez BL. Histoplasma, Blastomyces, Coccidioides and other dimorphic fungi causing systemic mycoses. In: Manual of Clinical Microbiology (ASM Press) 11th Ed. 2015
  8. Thompson GR III, Patterson TF. Antifungal Drugs: Mechanisms of Action, Drug Resistance, Susceptibility Testing, and Assays of Activity in Biological Fluids. In: Antibiotics in Laboratory Medicine 6th Ed. Lippincott Williams and Wilkins, c2014.
  9. Thompson GR III, Patterson TF. Cryptococcus species. In: Long SS, Pickering LK, Prober CG (Eds). Principles and Practice of Pediatric Infectious Diseases 4th Ed. New York: Churchill Livingstone, c2011.
  10. Thompson GR III, Patterson TF. Antifungal Agents. In: Maschmeyer, Rolston (Eds) Infections in Hematology. Springer, c2011.
  11. Thompson GR III, Patterson TF. Traditional Opportunistic Pathogens: Aspergillus, Candida and Cryptococcus. In: Robert H. Rubin (Ed.) Clinical Approach to Infection in the Compromised Host 5th Ed. Kluwer Academic/Plenum Publishers, c2011.
  12. Thompson GR III, Patterson TF. Antifungal drug profiles – Azoles. In: Alessandro Comarú Pasqualotto (Ed.) Aspergillus from diagnosis to prevention 3rd Ed. (pp. 231-262) Springer, c2009.
  13. Ampel N, Einstein HE, Galgiani JN, Pappagianis D, Wieden MA. Coccidioidomycosis. In: Atlas of Infectious Diseases, Fungal Infections, G.L. Mandell, and R.D. Diamond, (Eds.), 2000 Chapter 2, Current Medicine, Philadelphia, PA, p.24-37.
  14. Pappagianis D. Coccidioidomycosis. In: "Nelson Textbook of Pediatrics" 16th Edition, R.E. Behrman, R.M. Kliegman, H.B. Jenson (Eds.) 1999 Saunders Co., Chapter 236, pp. 942-944.
  15. Pappagianis D. Coccidioides immitis. In: Topley & Wilson’s Microbiology and Microbial Infections, Ninth Edition, L. Collier, A. Ballows, M. Sussman, eds., vol. 4, Medical Mycology, L. Ajello, R.J. Hay, eds., Arnold Publishers, Inc., Chapter 19, pp. 357-371. 1998
  16. Pappagianis D. Coccidioidomycosis, In: Clinical Dermatology D.J. Demis et al. (Eds.) J. Lippincott Company, Philadelphia, Unit (Chapter) 17-18, Vol. 3. 1997
  17. Pappagianis D, and Chandler FW. Coccidioidomycosis. In: Pathology of Infectious Diseases. Chapter 105, Vol. II, Appleton & Lange, Stamford, CT. pp. 977-987. 1997
  18. Pappagianis D. Clinical presentation of infectious entities, p.9-11, In H. Einstein and A. Cantanzaro (eds), Proceedings of the 5th Centennial Conference on coccidioidomycosis. National Foundation for Infectious Diseases, Bethesda, MD. 1996
  19. Pappagianis D. Immunoprophylaxis and immunotherapy. In: “Immunology, A Short Course”, 3rd Edition, E. Benjamini, G. Sunshine and S. Leskowitz (Eds.) Wiley-Liss, Inc., New York, Chapter 22. pp. 421-451. 1996
  20. Pappagianis D. Coccidioidomycosis. In: "Textbook of Pediatrics" 15th Edition, W.E. Nelson, R.E. Behrman, R.M. Kliegman, A.M. Arvin (Eds.) Saunders Co., Chapter 233, pp. 946-948. 1995
  21. Davidson, A., and Pappagianis, D. Treatment of nasal aspergillosis with topical clotrimazole. In: J.D. Bonagura and R.W. Kirk (eds.), Kirk's Current Veterinary Therapy XII Small Animal Practice. W.B. Saunders Company. pp.899-901. 1995
  22. Pappagianis, D. Coccidioidomycosis, In "Clinical Dermatology" D.J. Demis et al. (Eds.) J. Lippincott Company, Philadelphia, Unit (Chapter) 17-18, Vol. 3. 1993
  23. Pappagianis D. Immunoprophylaxis and immunotherapy. In: "Immunology, A Short Course 2nd Edition, E. Benjamini and S. Leskowitz, (Eds.) Wiley-Liss, Inc., New York, Chapter 21, pp.391-422. 1991
  24. Pappagianis D. Coccidioidomycosis. In: "Textbook of Pediatrics" 14th Edition, R.E. Behrman, R.M. Kliegman, W.E. Nelson and V.C. Vaughan III (Eds.) Saunders Co., Chapter 12, pp. 870-872. 1991
  25. Pappagianis D. Coccidioidomycosis. In: "Laboratory Diagnosis of Infectious Diseases". Balows, A. et al., (Eds.) Springer-Verlag, Vol. 1, p.600-623. 1988
  26. Pappagianis D. Enhancement of host resistance by control of fungal growth. In: Perspectives in antiinfective therapy, G.G. Jackson, H.D. Schlumberger, H.J. Zeiler, Editors. Proceedings of the Bayer AG Centenary Symposium, Washington, D.C. Current Topics in Infectious Diseases and Clinical Microbiology. vol. 2, pp.186-194. 1988
  27. Pappagianis D. Immunoprophylaxis and immunotherapy. In:"Immunology: A Short Course". E. Benjamini and S. Leskowitz (Ed.). Allan R. Liss, Inc., N.Y. Chapter 20, pp. 331-355. 1988
  28. Pappagianis D. Epidemiology of Coccidioidomycosis. In: "Current Topics in Medical Mycology". Michael R. McGinnis, (Ed.) Springer-Verlag, New York. Vol. 2, p.199-238. 1988
  29. Pappagianis D. Coccidioidomycosis. In: "Nelson Textbook of Pediatrics" 13th Edition, V.C. Vaughan and R.E. Behrman (Eds.) Saunders Co., Chapter 11, pp. 719-721. 1987
  30. Zimmer BL and Pappagianis D. Taxonomic and physiologic characteristics of Coccidioides immitis. In: Microbiology - 1986, L. Leive, (Ed.). American Society of Microbiology. Wash. D.C. p. 165-168. 1986
  31. Pappagianis, D. Coccidioidomycosis. In "Models in Dermatology", H. Maibach and N. Lowe (Eds.). S. Karger, Basel, Volume 1, pp. 98-104. 1985
  32. Pappagianis, D. Coccidioidomycosis, In "Clinical Dermatology" D.J. Demis et al. (Eds.) Medical Department, Harper and Row Publishers, Philadelphia, Unit (Chapter) 17-18, Vol. 3. 1984
  33. Pappagianis D. Coccidioidomycosis. In "Occupational Mycoses" A. DiSalvo (Ed.). Lea and Febiger, Philadelphia, Chapter 2, pp. 13-28. 1983
  34. Pappagianis D. Coccidioidomycosis. In "Communicable and Infectious Diseases" F.H. Top and P.F. Wehrle (Eds.), C.V. Mosby Company, St. Louis, Mo., Chapter 16, pp. 170-179. 1981
  35. Pappagianis D. Immunoserologic Procedures in the Diagnosis and Management of Pulmonary Mycoses. In "Handbook on Fungus Diseases" H.E. Einstein (Ed.), American College of Chest Physicians, Park Ridge, Illinois, pp. 84-94. 1981
  36. Einstein HE, Pappagianis D. Coccidioidomycosis. In "Clinical Medicine" J.A. Spittell (Ed.-in-Chief), Harper and Row, Publishers, Philadelphia, Vol. 2, Chapter 112, pp. 1-7. 1981
  37. Pappagianis D. Epidemiology of Coccidioidomycosis. In "Coccidioidomycosis" D.A. Stevens (Ed.), Plenum Publishing Corporation, Chapter 4, pp. 63-85. 1980
  38. Pappagianis D. Serology and Serodiagnosis of Coccidioidomycosis. In "Coccidioidomycosis" D.A. Stevens (Ed.), Plenum Publishing Corporation, Chapter 6, pp. 97-112. 1980
  39. Kobayashi GS, Pappagianis D. Medical Mycology. Section X, Chapters 101-104 in "Gradwohl's Clinical Laboratory Methods and Diagnosis", 8th Edition, Sonnenwirth, A.C. and Jarrett, L. (Eds.), pp. 2201-2239, C.V. Mosby Co., St. Louis. 1980
  40. Pappagianis D. Coccidioidomycosis. In "Textbook of Pediatrics" V.C. Vaughan and R.J. McKay (Eds.) Saunders Co., Chapter 10, pp. 964-967. 1979
  41. Pappagianis D. Coccidioidomycosis (Valley Fever). In "Textbook of Medicine" 15th Edition, P.B. Beeson and W. McDermott (Eds.), W.B. Saunders, pp. 537-540. 1979
  42. Pappagianis D. Coccidioidomycosis. In "Immunological Diseases", Samter, M. (Ed.), pp. 681-691, Little, Brown and Company, Vol. I. 1978
  43. Pappagianis D, Levine HB. Focus on Coccidioidomycosis. American College of Chest Physicians (Monograph), pp. 1-13. 1978
  44. Pappagianis D. Coccidioidomycosis. In "Infectious Diseases" P. Hoeprich (Ed.) Harper & Row Publishers, Chapter 39, pp. 389-398. 1977
  45. Shifrine MJ, Thilsted J, Pappagianis D. Canine Transfer Factor. In "Transfer Factor, Basic Properties and Clinical Applications", Academic Press, pp. 349-357. 1976
  46. Pappagianis D. Coccidioidomycosis. In "Communicable and Infectious Diseases" F.H. Top and P.F. Wehrle (Eds.), C.V. Mosby Company, St. Louis, Mo., Chapter 16, pp. 184-194. 1976
  47. Chaparas SD, Levine HB, Scalarone GM, Pappagianis D. Cellular responses, protective immunity, and virulence in experimental coccidioidomycosis. In "Mycoses" Scientific Publ. No. 304, Pan American Health Organization, Washington, D.C., pp. 80-87. 1975
  48. Pappagianis D. Opportunism in Coccidioidomycosis (Chapter 20). In "Opportunistic Fungal Infections", E. Chick, A. Balows and M.L. Furcolow (Eds.), Charles C. Thomas, Springfiled, Illinois. 1975
  49. Pappagianis D. Coccidioidomycosis (Valley Fever). In "Cecil & Loeb Textbook of Medicine" 14th Edition, P.B. Beeson and W. McDermott (Eds.), W.B. Saunders. pp. 444-446. 1975
  50. Pappagianis D. Coccidioidomycosis. In "Nelson Textbook of Pediatrics" V.C. Vaughan and R.J. McKay (Eds.) Saunders Co., Chapter 10, pp. 747-749. 1975
  51. Pappagianis D, Smith CE. Coccidioidomycosis. In "Communicable and Infectious Diseases" F.H. Top and P.F. Wehrle (Eds.), C.V. Mosby Company, St. Louis, Mo., Chapter 14, pp. 152-161. 1972
  52. Pappagianis D. Serologic Studies. In "Infectious Diseases" P. Hoeprich (Ed.), Harper & Row Publishers, Chapter 13, pp. 137-146. 1972
  53. Pappagianis D. Skin Tests. In "Infectious Diseases" P. Hoeprich (Ed.), Harper & Row Publishers, Chapter 14, pp. 147-155. 1972
  54. Pappagianis D, Hoeprich P. Cutaneous Manifestations of Infectious Diseases. In "Infectious Diseases" P. Hoeprich (Ed.) Harper & Row Publishers, Chapter 6, pp. 71-77. 1972
  55. Pappagianis D. Coccidioidomycosis. In "Infectious Diseases" P. Hoeprich (Ed.) Harper & Row Publishers, Chapter 36, pp. 405-416. 1972
  56. Pappagianis D. Coccidioidomycosis, In "Clinical Dermatology" D.J. Demis et al. (Eds.) Medical Department, Harper and Row Publishers, Hagerstown, Md., Unit (Chapter) 17-18, Vol. 3. 1972
  57. Pappagianis D. Coccidioidomycosis. In "Immunological Diseases," Samter, M. (Ed.), pp. 652-661, Little, Brown and Company, Vol. I. 1971
  58. Kobayashi GS, Pappagianis D. Medical Mycology. Section 5, Chapters 92-95 in "Gradwohl's Clinical Laboratory Methods and Diagnosis", 7th Edition, Frankel, S. (Ed.), pp. 1797-1839, C.V. Mosby Co., St. Louis. 1970
  59. Pappagianis D. Some characteristics of respiratory infection in man. In "An Introduction to Experimental Aerobiology" R.L. Dimmick and A.B. Akers, Eds., pp. 290-406, John Wiley and Sons, Inc. 1969

To Schedule an Appointment

Infectious Diseases

Internal Medicine Infectious Diseases Clinic

Lawrence J. Ellison Ambulatory Care Center
Department of Internal Medicine
4860 Y Steet — Suite 0101
Sacramento, CA 95817
916-734-2737

Donations

Donations support activities of the UC Davis Health Center for Valley Fever

Contact Us

Please contact for inquiries and questions about our Center for Valley Fever

Karryn DoyleKarryn Doyle, CCEP
Administrator
UC Davis Health
Center for Valley Fever
Department of Medical Microbiology and Immunology
kddoyle@ucdavis.edu

Connect with us

Tweets by @Cocci_Doctor

Valley Fever Events Calendar

Coccidioidomycosis Study Group (Tucson, Arizona)
March 31 - April 1, 2023